Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Rosing

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Thrombosis and Haemostasis|February 24, 2006
Protein S levels modulate the activated protein C resistance phenotype induced by elevated prothrombin levelsJeroen M Brugge, Guido Tans, Jan Rosing, et al.
Seminars in Vascular Medicine|June 17, 2004
Changes of hemostatic variables during oral contraceptive useGuido Tans, Bonno N Bouma, Harry R Büller, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2006
Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitorTilman M Hackeng, Kristin M Seré, Guido Tans, et al.
The Journal of Biological Chemistry|June 4, 2008
Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparinKenneth Segers, Björn Dahlbäck, Jan Rosing, et al.
Thrombosis and Haemostasis|May 26, 2012
The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor XaSameera Peraramelli, Dennis P L Suylen, Jan Rosing, et al.
Seminars in Hematology|January 24, 2006
Protein S multimers are generated in vitro and affect protein S structure-function analysesKristin M Seré, George M Willems, Jan Rosing, et al.
Thrombosis and Haemostasis|September 28, 2006
A structural model of the SHBG domain of human variant protein S HeerlenGerry A F Nicolaes, Tilman M Hackeng, Kenneth Segers, et al.
Thrombosis and Haemostasis|June 4, 2004
The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activitiesRory R Koenen, Lucio Gomes, Guido Tans, et al.
Blood|June 18, 2005
An underestimated combination of opposites resulting in enhanced thrombotic tendencyPaolo Simioni, Elisabetta Castoldi, Barbara Lunghi, et al.
Contraception|January 16, 2017
Endogenous thrombin potential changes during the first cycle of oral contraceptive useCarolyn L Westhoff, Malcolm C Pike, Serge Cremers, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Thrombosis and Haemostasis|February 24, 2006
Protein S levels modulate the activated protein C resistance phenotype induced by elevated prothrombin levelsJeroen M Brugge, Guido Tans, Jan Rosing, et al.
Seminars in Vascular Medicine|June 17, 2004
Changes of hemostatic variables during oral contraceptive useGuido Tans, Bonno N Bouma, Harry R Büller, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 21, 2006
Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitorTilman M Hackeng, Kristin M Seré, Guido Tans, et al.
The Journal of Biological Chemistry|June 4, 2008
Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparinKenneth Segers, Björn Dahlbäck, Jan Rosing, et al.
Thrombosis and Haemostasis|May 26, 2012
The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor XaSameera Peraramelli, Dennis P L Suylen, Jan Rosing, et al.
Seminars in Hematology|January 24, 2006
Protein S multimers are generated in vitro and affect protein S structure-function analysesKristin M Seré, George M Willems, Jan Rosing, et al.
Thrombosis and Haemostasis|September 28, 2006
A structural model of the SHBG domain of human variant protein S HeerlenGerry A F Nicolaes, Tilman M Hackeng, Kenneth Segers, et al.
Thrombosis and Haemostasis|June 4, 2004
The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activitiesRory R Koenen, Lucio Gomes, Guido Tans, et al.
Blood|June 18, 2005
An underestimated combination of opposites resulting in enhanced thrombotic tendencyPaolo Simioni, Elisabetta Castoldi, Barbara Lunghi, et al.
Contraception|January 16, 2017
Endogenous thrombin potential changes during the first cycle of oral contraceptive useCarolyn L Westhoff, Malcolm C Pike, Serge Cremers, et al.
Pageof 8